chartexchange

CG Oncology Exceeds Even The 'Most Bullish Conversations;' Shares Break Out

Investor's Business Daily | Nov 16, 2026 11:07 AM EST

CG Oncology said Monday its experimental bladder cancer treatment cut the risk of recurrence by 68%. The biotech stock broke out.
The post CG Oncology Exceeds Even The 'Most Bullish Conversations;' Shares Break Out appeared first on Investor's Business Daily .

Read original article